ArticleScientific reports2020

Intravitreal ranibizumab reduced ocular blood flow and aqueous cytokine levels and improved retinal morphology in patients with diabetic macular edema.

Toru Mizui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.